Carter Grant Abel, MD in Annandale, NJ - Medicare Dermatology

Carter Grant Abel, MD is a medicare enrolled "Dermatology - Mohs-micrographic Surgery" physician in Annandale, New Jersey. He went to Georgetown University School Of Medicine and graduated in 1991 and has 33 years of diverse experience with area of expertise as Dermatology. His current practice location is 1465 State Route 31 S, Concourse At Beaver Brook, Annandale, New Jersey. You can reach out to his office (for appointments etc.) via phone at (908) 735-5100.

Carter Grant Abel is licensed to practice in New Jersey (license number MA61267) and he also participates in the medicare program. He may accept medicare assignments (which means he may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance) and his NPI Number is 1558347229.

Contact Information

	Carter Grant Abel, MD
	1465 State Route 31 S, Concourse At Beaver Brook, Annandale, NJ 08801-3129
	(908) 735-5100
	Not Available

Physician's Profile

Full Name	Carter Grant Abel
Gender	Male
Speciality	Dermatology
Experience	33 Years
Location	1465 State Route 31 S, Annandale, New Jersey
Accepts Medicare Assignments	May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance.

Medical Education and Training:

Carter Grant Abel attended and graduated from Georgetown University School Of Medicine in 1991

NPI Data:

NPI Number: 1558347229
Provider Enumeration Date: 12/15/2005
Last Update Date: 10/14/2015

Medicare PECOS Information:

PECOS PAC ID: 4486605995
Enrollment ID: I20050202000293

Medical Identifiers

Medical identifiers for Carter Grant Abel such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1558347229	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207ND0101X	Dermatology - Mohs-micrographic Surgery	MA61267 (New Jersey)	Primary
207NS0135X	Dermatology - Procedural Dermatology	202786-1 (New York)	Secondary
207NS0135X	Dermatology - Procedural Dermatology	MA61267 (New Jersey)	Secondary
207N00000X	Dermatology	MA61267 (New Jersey)	Secondary
207N00000X	Dermatology	2027861-1 (New York)	Secondary
207NI0002X	Dermatology - Clinical & Laboratory Dermatological Immunology	MA61267 (New Jersey)	Secondary
207NI0002X	Dermatology - Clinical & Laboratory Dermatological Immunology	202786-1 (New York)	Secondary
207ND0900X	Dermatology - Dermatopathology	MA61267 (New Jersey)	Secondary
207ND0900X	Dermatology - Dermatopathology	202786-1 (New York)	Secondary
207NP0225X	Dermatology - Pediatric Dermatology	MA61267 (New Jersey)	Secondary
207NP0225X	Dermatology - Pediatric Dermatology	202786-1 (New York)	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Carter Grant Abel is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Carter Grant Abel, MD 1465 State Route 31 S, Concourse At Beaver Brook, Annandale, NJ 08801-3129 Ph: (908) 735-5100	Carter Grant Abel, MD 1465 State Route 31 S, Concourse At Beaver Brook, Annandale, NJ 08801-3129 Ph: (908) 735-5100

News Archive

Study provides hope for stimulating remyelination in MS patients

Scientists at Joslin Diabetes Center, Harvard University, and the University of Cambridge have found that the age-related impairment of the body's ability to replace protective myelin sheaths, which normally surround nerve fibers and allow them to send signals properly, may be reversible, offering new hope that therapeutic strategies aimed at restoring efficient regeneration can be effective in the central nervous system throughout life.

Research: Two-year-old children with autism have enlarged brains

In 2005, researchers from the University of North Carolina at Chapel Hill found that 2-year-old children with autism have brains up to 10 percent larger than children of the same age without autism.

New combination chemotherapy may become clinical standard for metastatic castrate-resistant prostate cancer

For more than a decade, oncologists using cytotoxic chemotherapy to treat patients with advanced metastatic castration-resistant prostate cancer (mCRPC) have relied on the sequential use of single agent taxanes such as docetaxel and cabazitaxel. For example, docetaxel is commonly used as the "first-line" therapy, while cabazitaxel is used as the "second-line" therapy.

University of Iowa receives a $26.4M gift commitment from the Pappajohns

University of Iowa President Sally Mason announced today a $26.4 million gift commitment from longtime UI benefactors John and Mary Pappajohn of Des Moines - the largest single gift commitment ever for the UI from individual Iowa donors - and said it will provide the university's new interdisciplinary Institute for Biomedical Discovery with "the catalyst it needs to reach its full potential."

New insights into protein p75's role Alzheimer's disease

New research at the Salk Institute for Biological Studies casts the role of a neuronal growth factor receptor - long suspected to facilitate the toxic effects of beta amyloid in Alzheimer's disease - in a new light, suggesting the molecule actually protects the neuron in the periphery from beta amyloid-induced damage.

Carter Grant Abel, MD - Medicare Dermatology in Annandale, NJ